Maravai Q3 revenue $41.6M, net loss $45.1M, Adj EBITDA -$10.8M

MARAVAI LIFESCIENCES HOLDINGS, INC.

2025-Q3 EPS reported -$0.66 revenue$135,877,000

Revenue of $41.6 million, net loss of $45.1 million, and Adjusted EBITDA loss of $10.8 million for Q3 2025.
Full-year 2025 revenue guidance of approximately $185 million, excluding potential high-volume CleanCap orders.
CEO expects double-digit sequential revenue growth in Q4 2025, citing strong funnel and order velocity at TriLink.
Organizational restructuring and operating cost reduction initiatives remain on track.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.